Wildcard: BICO, Bioprinting, and Bioconvergence
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Wildcard: BICO, Bioprinting, and Bioconvergence
-
Narrated by:
-
By:
About this listen
We get back to Wednesday's healthcare roots with a rundown on BICO Group, a Sweden-based business that enables researchers and scientists to model, build, test, analyze and observe 3-D printed cells, tissues and organs.
This company helps researchers reduce the time and cost of identifying potentially efficacious drugs and can help provide initial results on whether drug compounds are safe and effective before having to test them on animals or humans.
We talk through the huge implications it could have for research in life sciences and personalized medicine and try to clear up some of the jargon around the company.
Stocks: (OM:BICO)
Check out more of our content here:
Podcasts
Youtube
Reach us by Email @ IndustryFocus@fool.com
activate_mytile_page_redirect_t1
What listeners say about Wildcard: BICO, Bioprinting, and Bioconvergence
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.